Early insight and the management of schizophrenic decompensation

Journal of Nervous and Mental Disease

Volumn 173, Issue 3, 1985, Pages 133-138

  Heinrichs, Douglas W ^a   Cohen, Barry P ^a   Carpenter, William T ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; HOSPITALIZATION; HUMAN; PRIORITY JOURNAL; RELAPSE; SCHIZOPHRENIA; THERAPY;

ADULT; AFTERCARE; AMBULATORY CARE; ANTIPSYCHOTIC AGENTS; COGNITION; FEMALE; HUMAN; MALE; MEDICAL RECORDS; MIDDLE AGE; PATIENT READMISSION; PSYCHOTHERAPY; RECURRENCE; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF CONCEPT; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0021978510     PISSN: 00223018     EISSN: 1539736X     Source Type: Journal    
DOI: 10.1097/00005053-198503000-00001     Document Type: Article

References (31)

1. Carpenter, W. T., and Heinrichs, D. W. Early intervention, time-limited, targeted pharmacotherapy of schizophrenia. Schizophr. Bull., 9: 533-542,1983.
2. Carpenter, W. T., Stephens, J. H., Rey, A. C, et al. Early intervention vs. continuous pharmacotherapy of schizophrenia. Psychopharmacol. Bull, 18: 21-23,1982.
3. Carpenter, W. T., Strauss, J. S., and Bartko, J. J. A flexible system for the identification of schizophrenia: A report from the International Pilot Study of Schizophrenia. Science, 182: 1275-1278,1973.
4. Carpenter, W. T., Strauss, J. S., and Bartko, J. J. Use of signs and symptoms for the identification of schizophrenic patients: A report from the International Pilot Study of Schizophrenia. Schizophr. Bull., Winter: 37-49,1974.
5. Chapman, J. The early symptoms of schizophrenia. Br. J. Psychiatry, 112: 225-252, 1966.
6. Chapman, R., and Forrest, A. Controlled trial of depot fluphen-azine in outpatient schizophrenics. Br. J. Psychiatry, 124: 385-391, 1974.
7. Davis, J. M. Overview: Maintenance therapy in psychiatry: I. Schizophrenia. Am. J. Psychiatry, 132:1237-1245,1975.
8. Del Giudice, J., Clark, W. G., and Gock, E. F. Prevention of recidivism of schizophrenics treated with fluphenazine en-anthate. Psychosomatics, 16: 32-36, 1975.
9. Docherty, J. P., Van Kammen, D. P., Siris, S. G., and Marder, S. R. Stages of onset of schizophrenic psychosis. Am. J. Psychiatry, 135:420-426, 1978.
10. Donlon, P. T., and Blacker, K. H. Stages of schizophrenic decompensation and reintegration. J. Nerv. Ment. Dis., 157: 200-209, 1973.
11. Exner, J., and Murillo, L. Early prediction of posthospitaliza-tion relapse. J. Psychiatr. Res., 12: 231-237, 1975.
12. Falloon, I., Watt, D. C, and Shepherd, M. A comparative controlled trial of pimozide and flupriena^ine decanoate in the continuation therapy of schizophrenia. Psychol. Med., 8: 59-70,1978.
13. Heinrichs, D. W., and Carpenter, W. T. Prospective Study of Prodromal Symptoms in Schizophrenic Relapse. Paper presented at the annual meeting of the American Psychiatric Association, New York, May 1983.
14. Herz, M., and Melville, C. Relapse in schizophrenia. Am. J. Psychiatry, 137: 801-805, 1980.
15. Herz, M., Szymanski, H. V., and Simon, J. C. Intermittent medication for stable schizophrenic outpatients: An alternative to maintenance medication. Am. J. Psychiatry, 139:918-922, 1982.
16. Hogarty, G. E., Goldberg, S. C, Schooler, N. R., and Ulrich, R. F. Drug and sociotherapy in the aftercare of schizophrenic patients: II. Two-year relapse rates. Arch. Gen. Psychiatry, 31: 603, 1974.
17. Hogarty, G. E., Schooler, N. R., and Ulrich, R. F, et al. Fluphenazine and social therapy in the aftercare of schizophrenic patients: Relapse analyses of a two-year controlled trial. Arch. Gen. Psychiatry, 36:1283-1294,1979.
18. Jaspers, K. General Psychopathology (Hoenig, J., and Hamilton, M. W., Transl.). University of Chicago Press, Chicago, 1963.
19. Kane, J., Rifkin, A., Woemer, M., et al. Low dose neuroleptic treatment of outpatient schizophrenics. Arch. Gen. Psychiatry, 40: 893-896,1983.
20. Lin, I. F., Spiga, R., and Fortsch, W. Insight and adherence to medication in chronic schizophrenics. J. Clin. Psychiatry, 40: 430-432,1979.
21. Overall, J. E., and Gorham, D. R. The Brief Psychiatric Rating Scale. Psychol. Rep., 10: 799-812,1962.
22. Rifkin, A., Quitkin, F., Rabiner, C. J., and Klein, D. F. Flu-phenazine decanoate, fluphenazine hydrochloride given orally, and placebo in remitted schizophrenics: I. Relapse rates after one year. Arch. Gen. Psychiatry, 344: 43-47,1977.
23. Roback, H. B., and Abramowitz, S. I. Insight and hospital adjustment. Can. J. Psychiatry, 24: 233-236,1979.
24. Sarwer-Foner, G. J. The role of neuroleptic medication in psychotherapeutic interaction. Compr. Psychiatry, 1: 291-300, 1960.
25. Schooler, N. R., Levine, J., Severe, J. B., et al. Prevention of relapse in schizophrenia. Arch. Gen. Psychiatry, 37: 16-24, 1980.
26. Simon, P., Fermanian, J., Ginestet, D., et al. Standard and long-acting depot neuroleptics in chronic schizophrenics. Arch. Gen. Psychiatry, 35: 893-897, 1978.
27. Soskis, D. A., and Bowers, M. B. The schizophrenic experience: A follow-up study of attitude and posthospital adjustment. J. Nerv. Ment. Dis., 149: 443-449, 1969.
28. Spitzer, R. L., Endicott, J., and Robins, E. Research diagnostic criteria (RDC). Psychopharmacol. Bull, 11: 22-24,1975.
29. Strauss, J., and Carpenter, W. T. The prediction of outcome in schizophrenia II. Relationships between predictor and outcome variables: A report from the WHO International Pilot Study of Schizophrenia. Arch. Gen. Psychiatry, 31: 37-42, 1974.
30. Van Putten, T., Crumpton, E., and Yale, C. Drug refusal and the wish to be crazy. Arch. Gen. Psychiatry, 33: 1443-1446, 1976.
31. World Health Organization, Eds. Report of the International Pilot Study of Schizophrenia, Vol. 1. World Health Organization, Geneva, 1974.